ValueAct Capital Master Fund, L.P.
CIK 1464912 · last filed 2025-05-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
STX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BUILDING D, 4TH FLOOR
SAN FRANCISCO, CA 94129
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NSIT | Director | 3,461,739 | $178.44 | $617.71M | -$549.95M | 2 | 2025-05-12 |
| CRM | Director | 3,486,863 | $241.29 | $841.35M | $0 | 1 | 2023-05-23 |
| STX | Director | 15,487,070 | $671.34 | $10.40B | -$4.12B | 4 | 2021-11-15 |
| CBRE | Director | 9,232,609 | $121.84 | $1.12B | -$768.52M | 1 | 2021-08-12 |
| LKQ | Director | 21,552,751 | $17.13 | $369.20M | $0 | 1 | 2021-05-13 |
| BHC | Director | 17,960,285 | $6.28 | $112.70M | $0 | 1 | 2021-05-03 |
| AWI | Director | 1,240,152 | $155.19 | $192.47M | -$1.72B | 7 | 2019-06-21 |
| ACA | 4,240,963 | $149.15 | $632.54M | -$378.31M | 1 | 2019-06-14 | |
| CBRE GROUP, INC. (CBG) Delisted | Director | 19,925,987 | — | — | -$2.91B | 7 | 2018-03-02 |
| KKR | 10%+ Owner | 49,700,000 | $92.14 | $4.58B | $73.62M | 1 | 2018-02-13 |
| TRN | 10%+ Owner | 18,607,352 | $25.43 | $473.28M | $64.32M | 2 | 2017-11-27 |
| WILLIS TOWERS WATSON PLC (WLTW) Delisted | Director | 2,812,595 | $231.56 | $651.28M | -$1.72B | 6 | 2017-10-13 |
| MSFT | Director | 8,131,525 | $532.20 | $4.33B | $0 | 2 | 2017-08-31 |
| BREAD FINANCIAL HOLDINGS, INC. (ADS) Delisted | 10%+ Owner | 5,845,000 | $56.80 | $332.00M | $75.27M | 1 | 2017-01-30 |
| ALSN | Director | 10,525,204 | $107.22 | $1.13B | $0 | 2 | 2016-12-02 |
| FOXA | Director | 2,400,000 | $64.33 | $154.39M | $703.64M | 2 | 2016-08-18 |
| MSCI | Director | 3,674,969 | $601.52 | $2.21B | -$41.27M | 2 | 2016-05-09 |
| ADBE | Director | 9,426 | $248.18 | $2.34M | -$2.20B | 4 | 2016-04-13 |
| WILLIS TOWERS WATSON PLC (WSH) Delisted | Director | 6,954,549 | — | — | $260.90M | 3 | 2014-03-04 |
| OPENLANE, Inc. (KAR) Delisted | Director | 0 | $30.88 | $0 | -$1.28B | 2 | 2013-11-15 |
| IT | Director | 0 | $219.97 | $0 | -$1.38B | 6 | 2011-12-16 |
| IMMUCOR INC (BLUD) Delisted | 10%+ Owner | 7,540,665 | — | — | $38.30M | 2 | 2011-06-14 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | 10%+ Owner | 17,336,503 | — | — | $54.53M | 3 | 2009-07-10 |
Recent Filings · Page 10 of 11
110 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-04-25 | — | Sell (S) | −76,811 | -$7.77M | |
| 2013-04-01 | — | Sell (S) | −57,036 | -$5.76M | |
| 2012-10-01 | — | Sell (S) | −771,127 | -$81.02M | |
| 2012-06-06 | — | Grant (A) | +48,372 | $0 | |
| 2012-05-21 | — | Buy (P) | +5,100,000 | $245.89M | |
| 2012-05-16 | — | Buy (P) | +1,770,000 | $90.23M | |
| 2011-12-16 | IT | Sell (S) | −9,890,604 | -$348.15M | EDGAR |
| 2011-11-15 | IT | Sell (S) | −3,408,600 | -$131.92M | EDGAR |
| 2011-11-10 | IT | Sell (S) | −1,684,758 | -$65.63M | EDGAR |
| 2011-11-07 | IT | Sell (S) | −4,056,000 | -$160.00M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.